Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A5DJ
|
|||
| Former ID |
DIB001450
|
|||
| Drug Name |
Pancrecarb
|
|||
| Synonyms |
Pancrelipase (Digestive Care)
Click to Show/Hide
|
|||
| Indication | Pancreatic malfunction [ICD-11: DC30-DC3Z] | NDA filed | [1] | |
| Company |
Digestive Care Inc
|
|||
| ADReCS Drug ID | BADD_D01664 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Chymotrypsin (CTR) | Target Info | Modulator | [2], [3] |
| Pancreatic alpha-amylase (AMY2A) | Target Info | Modulator | [1] | |
| Pancreatic triacylglycerol lipase (PNLIP) | Target Info | Modulator | [1] | |
| BioCyc | Triacylglycerol degradation | |||
| Retinol biosynthesis | ||||
| KEGG Pathway | Glycerolipid metabolism | |||
| Metabolic pathways | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Vitamin digestion and absorption | ||||
| Reactome | Retinoid metabolism and transport | |||
| WikiPathways | Visual phototransduction | |||
| Lipid digestion, mobilization, and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Digestive Care. | |||
| REF 2 | US patent application no. 2012,0251,516, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT. | |||
| REF 3 | EP patent application no. 2490711, A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.